We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+8.85%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$48.5M
(+3.6%)
Cap. Flow
-$39M
Cap. Flow
% of AUM
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
12.95%
Holding
338
New
43
Increased
85
Reduced
162
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steven Madden
SHOO
|
+$10.8M |
| 2 |
World Acceptance Corp
WRLD
|
+$8.79M |
| 3 |
Marcus & Millichap
MMI
|
+$7.49M |
| 4 |
Murphy USA
MUSA
|
+$6.69M |
| 5 |
The Greenbrier Companies
GBX
|
+$6.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$11.8M |
| 2 |
LNW
Light & Wonder
LNW
|
+$9.56M |
| 3 |
Artisan Partners
APAM
|
+$8.34M |
| 4 |
CMD
Cantel Medical Corporation
CMD
|
+$6.41M |
| 5 |
CNO Financial Group
CNO
|
+$6.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.01% |
| 2 | Financials | 15.27% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Technology | 12.33% |
| 5 | Healthcare | 11.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Travere Therapeutics
TVTX
$5.29B
| – | – |
-22,632
| Closed | -$506K |
|
327
United Therapeutics
UTHR
$26B
| – | – |
-3,096
| Closed | -$348K |
|
328
Bristow Group
VTOL
$1.33B
| – | – |
-23,926
| Closed | -$447K |
|
329
V2X
VVX
$2.76B
| – | – |
-5,640
| Closed | -$210K |
|
|
CDK
330
DELISTED
CDK Global, Inc.
CDK
| – | – |
-5,818
| Closed | -$369K |
|
|
MGLN
331
DELISTED
Magellan Health Services, Inc.
MGLN
| – | – |
-8,109
| Closed | -$868K |
|
|
FIT
332
DELISTED
Fitbit, Inc. Class A common stock
FIT
| – | – |
-652,320
| Closed | -$3.33M |
|
|
GCAP
333
DELISTED
Gain Capital Holdings, Inc.
GCAP
| – | – |
-280,397
| Closed | -$1.89M |
|
|
FTD
334
DELISTED
FTD Companies, Inc. Common Stock
FTD
| – | – |
-257,211
| Closed | -$936K |
|
|
IMPV
335
DELISTED
Imperva, Inc.
IMPV
| – | – |
-7,003
| Closed | -$303K |
|
|
QCP
336
DELISTED
Quality Care Properties, Inc.
QCP
| – | – |
-120,678
| Closed | -$2.34M |
|
|
RPXC
337
DELISTED
RPX Corporation
RPXC
| – | – |
-532,688
| Closed | -$5.69M |
|
|
CELG
338
DELISTED
Celgene Corp
CELG
| – | – |
-18,472
| Closed | -$1.65M |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Matarin Capital Management held 338 positions worth $1.38B, up 3.6% from $1.33B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management's Q2 2018 filing shows 43 new, 85 increased, 162 reduced and 41 closed positions. Its largest new stake was Steven Madden: 321,614 shares worth $11.4M. The largest sale was Wellcare Health Plans, Inc., an estimated $11.8M.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- Matarin Capital Management's largest Q2 2018 buy was Steven Madden: 321,614 shares worth $11.4M.
- Matarin Capital Management added most to World Acceptance Corp in Q2 2018, an estimated $8.79M increase.
- Matarin Capital Management's biggest Q2 2018 reduction was Wellcare Health Plans, Inc., cutting an estimated $11.8M.
- Matarin Capital Management fully exited Artisan Partners in Q2 2018, selling an estimated $8.34M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.38B portfolio in Q2 2018.
- Matarin Capital Management opened 43 new positions and closed 41 in Q2 2018.
- Matarin Capital Management's portfolio value rose 3.6% quarter-over-quarter to $1.38B.
Based on Matarin Capital Management's 13F filing for Q2 2018, filed 17 Aug 2018.